Aralez Bio

About:

Aralez Bio uses engineered enzymes to make valuable products in a sustainable way.

Twitter/X: aralezbio

Top Investors: Paladin Capital Group, Good Growth Capital, Impact Science Ventures, Freeflow Ventures, Astia

Description:

Aralez Bio uses engineered enzymes to make valuable products in a sustainable way. The company has invented a novel enzymatic method for synthesizing noncanonical amino acids (ncAAs) also called unusual or unnatural amino acids. Its proprietary approach enables over 100 ncAAs to be synthesized with perfect enantiopurity in just a single step, with water as the only byproduct

Total Funding Amount:

$12M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Emeryville, California, United States

Founded Date:

2019-01-01

Contact Email:

contact(AT)aralezbio.com

Founders:

Christina Boville, David Romney, Frances Arnold, Lori Giver

Number of Employees:

11-50

Last Funding Date:

2024-10-29

IPO Status:

Private

Industries: